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Objective: To assess the role of head up tilt testing (HUT) in diagnosing probable or possible vasovagal syncope (VVS) in
patients referred from an epilepsy clinic.
Methods: One hundred thirty two patients underwent HUT over 36 months. Complete data were available on 128 patients (52
male) aged 14–80 (mean 36.7) years. The main indication for HUT (head up tilt at 70◦ for 45 minutes) was recurrent undiagnosed
blackouts, likely to be VVS. Patients were divided, prior to knowledge of the HUT results, into probable VVS, possible VVS,
or probable/possible VVS associated with definite epilepsy.
Results: HUT was positive in 72 patients (56%), and led to an alternative definite diagnosis in 31 (24%). Diagnostic change was
more likely in those provisionally labelled either as possible VVS (15 of 34; 44%) or as a combination of epilepsy with possible
or probable VVS (12 of 19; 63%) compared to those with probable VVS (4 of 75; 5%; P < 0.01).
Of the 45 patients previously treated with antiepileptic medications 27 did not have epilepsy.
Conclusion: HUT has an important role in confirming or refuting the diagnosis of VVS in patients presenting with undiagnosed
blackouts to an epilepsy clinic, and particularly so in patients with possible rather than probable VVS, and in those thought to
have a combination of epilepsy and possible or probable VVS.
© 2003 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Syncope accounts for about 3–5% of visits to emer-
gency departments, and 1% of hospital admissions1.
Vasovagal syncope (VVS) typically occurs in oth-
erwise healthy individuals, whereas orthostatic and
cardiac syncope usually accompany autonomic neu-
ropathy or heart disease. The diagnosis of VVS rests
principally upon the history; investigations other than
electrocardiogram are often unnecessary. However,
distinguishing VVS from seizures is occasionally
difficult, especially without a clear witness account.
Limb jerking is surprisingly common in VVS2 and
incontinence and injury may also occur. Clinical ex-
amination is rarely helpful in distinguishing the two;
even lying and standing blood pressure (BP) is typi-
cally unchanged in patients with a history of VVS.
There is a clear need to improve syncope diagnosis
and to optimise the application of available diagnostic
techniques. Head up tilt table testing (HUT) is used
increasingly to assist the evaluation of patients with
VVS. Based upon an analysis of pooled data3 Linzer
et al.4 recommended passive upright HUT for pa-
tients with recurrent unexplained syncope in whom
cardiac causes, including arrhythmias, had been ex-
cluded. Most protocols involve passive upright tilt at
60–80◦ for 45 minutes. The response in normal in-
dividuals is a transient fall (5–15 mmHg) in systolic
BP with a rise of diastolic BP of 5–10 mmHg; the
heart rate (HR) may rise between 5 and 15 beats per
minute. Patients with a history of VVS usually show
more marked changes: a pure vasodepressor response
(BP fall exceeding 20 mmHg), a cardio-inhibitory re-
sponse (HR fall exceeding 10% of the baseline rate),
or a mixed response.
We have evaluated the role of HUT in assisting the
diagnosis of patients with recurrent blackouts referred
from an epilepsy clinic.
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METHODS
All patients referred for HUT from the University
Hospital of Wales epilepsy clinic over 36 months
(1998–2001) were included. Referral criteria were in
line with published consensus guidelines for HUT5
and therefore included patients with recurrent un-
diagnosed blackouts, likely to be VVS, in whom
heart disease was either not suspected or had been
excluded. Those in whom a diagnosis of VVS ap-
peared obvious were not referred for HUT. Patients
completed a proforma at the time of HUT giving
details of associated symptoms including postural
pre-syncope, incontinence, injury, tongue biting, and
of antiepileptic medication.
One of us (S.S.M. Razvi), not involved in the clinical
consultations and without knowledge of the HUT re-
sult, used the clinic notes and completed proformas to
categorise each patient into one of three broad groups:
‘probable VVS’ (strong suspicion of syncope), ‘pos-
sible VVS’ (lesser suspicion of syncope), or ‘epilepsy
with probable or possible VVS’.
The HUT protocol followed standard guidelines in-
volving 70◦ upright tilt for up to 45 minutes, with con-
tinuous BP and HR monitoring (Finapres). All HUTs
were supervised by one of the authors (J. Pascual).
Table 1: Criteria for positive and negative HUT.
Positive test
Typical symptoms accompanying one of the following
BP fall by >20 mmHg.
BP fall by >20 mmHg with HR fall >10% of baseline.
Postural tachycardia (HR increase by ≥30 BPM or
maximum of 120 BPM in the first 10 minutes of
HUT accompanied by symptoms).
BP fall by >20 mmHg induced by cough, carotid
massage, isoprenaline, or glyceryl trinitrate.
Negative test
One of the following
BP fall <20 mmHg or HR fall >10% of baseline
alone (vasovagal tendency).
BP fall by >20 mmHg without typical symptoms.
Typical symptoms without haemodynamic changes
(true negative).
Table 2: Provisional diagnoses before HUT (horizontal), re-classified following completion of investigation (vertical).
Probable VVS Possible VVS Epilepsy with probable Total (post-HUT)
(n = 75) (n = 34) or possible VVS (n = 19)
VVS 64 16 2 82
Epilepsy with VVS 0 3 5 8
Epilepsy 1 6 9 16
Other diagnosis 3 6 1 10
Uncertain 7 3 2 12
Total (pre-HUT) 75 34 19 128
The haemodynamic responses to cough and to carotid
massage were assessed where clinically relevant, and
isoprenaline or glyceryl trinitrate sublingual spray was
administered following an initial negative test if there
was still strong clinical suspicion of VVS. Lying and
standing BP were recorded in all patients. The criteria
for positive and negative HUT are shown in Table 1.
The Statistical Package for Social Sciences (SPSS)
version 9.0 was used for statistical analysis, utilising
Fisher’s exact test (two-tailed).
RESULTS
One hundred thirty two patients were referred for
HUT over 36 months. Complete clinical and labora-
tory data before testing were available on 128 patients
(52 male), aged 14–80 (mean 36.7± 5.5 [SD]) years,
and the analysis was based upon these. HUT was pos-
itive in 72 of the 128 (56%) patients. A change to
an alternative definite diagnosis followed HUT in 31
cases (24%; Table 2).
Changes in diagnosis
All patients followed up after a positive HUT were
given a final diagnosis of VVS, with or without ac-
companying epilepsy. The HUT results and changes
in diagnosis with respect to the provisional diagnostic
groupings were as follows.
• Probable VVS: HUT was positive in 49 of the
75 (65%) with this provisional diagnosis; 22 of
the remainder (29%) were considered still to have
VVS, even after a negative test. The diagnosis was
changed to an alternative definite diagnosis in only
4 of the 75 (5%), 1 to epilepsy, and 3 to other dis-
orders.
• Possible VVS: HUT was positive in 16 of the 34
(47%) with this provisional diagnosis; 16 had a
final diagnosis of syncope (14 HUT positive) and
3 had a combination of epilepsy with syncope (2
HUT positive). The diagnosis was subsequently
changed to an alternative definite diagnosis in 15
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(44%), 6 to epilepsy, 3 to epilepsy with VVS, and
6 to other disorders.
• Epilepsy with probable/possible VVS: HUT was
positive in 6 of the 19 (32%) with this provisional
diagnosis. This was the final diagnosis in only 5
of this group, 4 of whom had a positive HUT. The
diagnosis was changed to an alternative definite
diagnosis in 11 (58%), with epilepsy excluded in
2, and VVS considered excluded in 9.
A change in diagnosis was therefore significantly more
likely (Fisher’s exact test) in the groups categorised
prior to HUT as either possible VVS or as epilepsy
with probable or possible VVS, compared to the prob-
able VVS group (P < 0.01).
HUT result details
The HUT results with respect to the final diagnostic
groupings were as follows.
• VVS group: of the patients with a final diagnosis
of VVS (n = 82), HUT was positive in 65 (79%);
38 with BP fall alone, 20 with BP and HR fall, 1
with postural tachycardia, 3 with haemodynamic
changes following carotid massage, 2 following
cough, and 1 with haemodynamic changes only
following isoprenaline infusion.
• VVS with epilepsy: of those with a final diagnosis
of VVS and epilepsy (n = 8), HUT was positive
in six (75%); two with BP fall alone, three with BP
and HR fall, and one with haemodynamic changes
only during carotid massage.
• Epilepsy alone: of those with a final diagnosis of
epilepsy alone (n = 16), HUT was negative in all;
this included four with significant BP fall without
accompanying symptoms and one with a vasovagal
tendency only.
• Other disorders: HUT was negative in all 10 pa-
tients in this group, including 1 showing a vasova-
gal tendency only.
• Uncertain: of those in whom no certain final diag-
nosis was made, one had a positive HUT (BP fall
with symptoms) but was subsequently lost to fol-
low up and no definite diagnosis established, and
one showed vasovagal tendency only.
Postural pre-syncope symptoms during attacks were
reported by 47 of 128 (37%) patients, but a postural
fall in BP was documented before HUT in only 4.5%.
However, postural pre-syncope was significantly more
likely in patients whose final diagnosis was VVS (37
of 81 patients; 46%), rather than those diagnosed as
epilepsy (2 of 16 patients; 12.5%; P < 0.05). Fifty
one patients (40%) reported physical injury (exclud-
ing tongue biting) during blackouts, and this was sig-
nificantly more likely in those diagnosed as epilepsy
(10 of 16; 63%) than in those diagnosed as VVS (28
of 82; 34%; P < 0.05). Tongue biting during episodes
occurred in 15 of the 128 patients (12%), but was no
more likely among those subsequently diagnosed as
epilepsy (4 of 15; 27%) than among those with a fi-
nal diagnosis of VVS (7 of 82; 9%; P = 0.064, NS).
Urinary incontinence accompanied attacks in 29 pa-
tients (23%), including 5 of 15 (33%) subsequently
diagnosed as epilepsy alone, and 20 (24%) diagnosed
as VVS (NS).
Antiepileptic medications were currently or previ-
ously prescribed in 45 (35%) patients, yet epilepsy
was not the diagnosis in 27 (60%) of these. Indeed,
antiepileptic medications had been prescribed to 21 of
the 82 patients (25%) diagnosed as VVS alone and
to 4 of the 10 patients (40%) with either psychogenic
non-epileptic attack disorder or other non-epilepsy di-
agnoses.
DISCUSSION
We have shown that head up tilt table testing (HUT)
has an important role in confirming or refuting the di-
agnosis of VVS in patients with undiagnosed black-
outs presenting to an epilepsy clinic, aiding a change
in diagnosis in about a quarter of such patients.
Our patients do not represent a population with
either syncope or unspecified blackouts, for two rea-
sons. Firstly, cases were ascertained from a specialist
epilepsy clinic, possibly over-representing epilepsy
compared to a community-ascertained group, and
secondly, those in whom VVS was either obvious or
unlikely were not included. Nevertheless, our sample
does represent those patients most likely to be re-
ferred for HUT, i.e. recurrent undiagnosed blackouts,
with VVS considered a possible or probable diagno-
sis, and where heart disease is either not suspected or
has been excluded.
This study was retrospective, with the pre-test and
final diagnoses derived from available case notes.
Also, being a study of usual clinical practice, the HUT
was not the sole determinant of the final diagnosis.
Prior knowledge of the clinical history at the time
of HUT may have evoked observer bias in its inter-
pretation, though consistency was maximised by all
tilt tests being supervised and evaluated by one clin-
ician, using previously agreed criteria. The pre-test
categorisation into probable and possible VVS was
also liable to observer bias, though again minimised
by the classifying clinician being independent of the
original consultations and having no prior knowledge
of the HUT results.
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VVS episodes, particularly when accompanied
by convulsive features, are commonly mistaken for
seizures6. Lempert et al.2 demonstrated that my-
oclonus, usually multifocal, accompanies 90% of
syncope induced in healthy volunteers and that addi-
tional features such as head turning, oral movement
or attempts to sit up occur in 80%. It is perhaps not
surprising, therefore, that VVS is frequently identi-
fied among patients labelled and treated as epilepsy7
perhaps accounting for 26% of patients with a di-
agnosis of refractory epilepsy8. The costs of misdi-
agnosing patients as having drug resistant epilepsy
are considerable9 aside from the inconvenience and
risk of unnecessary antiepileptic drug exposure, e.g.
during pregnancy. These data highlight the poten-
tial value of HUT in seeking alternative diagnoses
in cases of resistant ‘known epilepsy’. There is a
clear need to improve awareness and availability of
techniques for diagnosing VVS.
The evaluation of diagnostic techniques almost in-
variably lags behind that of treatments10. A particu-
lar problem in considering the accuracy and clinical
usefulness of many diagnostic tests is the absence of
a suitable reference standard or ‘gold standard’ for
diagnosis. VVS is a good example of there being a
spectrum of susceptibility within the healthy popula-
tion with no clear cut divide between ‘normal’ and
‘abnormal’. Furthermore, the diagnosis of recurrent
blackouts relies principally upon the clinical history,
which is often incomplete from the patient, or lacking
a witness account. The clinical diagnosis can be as-
sisted by investigations, but the diagnosis of recurrent
blackouts only rarely rests upon a single laboratory
result.
The sensitivity of HUT for VVS (probability of a
positive test in people with VVS) has been previously
estimated at between 67 and 85%11, 12. The specificity
for VVS (probability of negative test in people without
VVS) is around 90%13, although far less if high dose
isoproterenol is used. Our study excluded patients with
definite VVS and so we cannot derive an estimate of
sensitivity of HUT for VVS from our data. Among the
population studied, however, the sensitivity of HUT
was 71 out of 90 (79%). It would be realistic to say that
the false positive rate in epilepsy can be determined
only by further studies in this specific group.
Another point to ponder is the issue of potential ad-
verse outcomes. HUT is contraindicated in patients
with significant ischaemic heart disease and in preg-
nant women. Several centres in the United States per-
form a stress test prior to HUT in high-risk individuals.
However, the relative incidence of adverse effects is
minimal. Problems usually encountered are secondary
to haemodynamic changes and include hypotension,
tachycardia and bradycardia associated with ortho-
static intolerance, pre-syncope and syncope. Occa-
sionally chest pain, coronary vasospasm and tach-
yarrhythmia may occur, especially after provocative
testing with a pharmaceutical agent3. Dhala et al.14 re-
ported a 9% incidence of asystolic reactions on HUT
among 209 patients tested for neurocardiogenic syn-
cope. These events however, were transient and did not
affect long-term outcome measures. They compared
with a 3% incidence among 75 healthy volunteers.
This figure probably represents the expected incidence
of adverse effects of HUT in patients with epilepsy.
Our results highlight the value of HUT in assisting
the diagnosis of recurrent blackouts but we cannot
quantify its contribution precisely from retrospective
data. We are currently planning to evaluate HUT
prospectively in patients with undiagnosed blackouts.
A randomised controlled trial would be necessary
to study its true impact on diagnosis and clini-
cal decision-making, but devising a HUT placebo
presents a practical challenge. One solution, if eth-
ically permissible, might be to apply the HUT to
all, but to randomise disclosure of its results to the
clinicians involved. Wider availability of HUT may
allow its selective use to support clinical management
by increasing the certainty of a diagnosis of VVS in
patients presenting with undiagnosed blackouts.
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